ATLAS / Macro Radar / Reporting / SGMT

Sagimet Biosciences Inc. (SGMT) reporting calendar

Sagimet Biosciences Inc. files periodic reports with the SEC as SGMT on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
28 Jul 2026 – 29 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
12

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open SGMT market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001104659-26-059006
10-K31 Dec 202511 Mar 202670 days0001104659-26-026140
10-Q30 Sep 202513 Nov 202544 days0001104659-25-110846
10-Q30 Jun 202513 Aug 202544 days0001558370-25-011301
10-Q31 Mar 20258 May 202538 days0001558370-25-006836
10-K31 Dec 202412 Mar 202571 days0001558370-25-002747
10-Q30 Sep 202414 Nov 202445 days0001558370-24-015623
10-Q30 Jun 202414 Aug 202445 days0001558370-24-012136
10-Q31 Mar 202415 May 202445 days0001558370-24-008205
10-K31 Dec 202325 Mar 202485 days0001558370-24-003812
10-Q30 Sep 202313 Nov 202344 days0001558370-23-018700
10-Q30 Jun 202321 Aug 202352 days0001104659-23-093910

Source: SEC EDGAR company submissions for CIK 0001400118. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.